Phase 2a Study to Evaluate the Safety and Efficacy of PH100 Tablet in T2DM Patients With Recent Cardiovascular

NCT04141241 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus With Circulatory Complciation

Interventions

DRUG: Ecklonia cava Phlorotannin

Sponsor

Bota Bio Co., Ltd.